Peter Scheurich
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Immunology top 0.5%
- T-cell and B-cell Immunology
- Immune Response and Inflammation
Papers in
-
- NF-κB Signaling Pathways 45
- Immunology 34
- T-cell and B-cell Immunology 12
- Immune Response and Inflammation 11
- Co-authors
- Harald Wajant (37 shared papers)Klaus Pfizenmaier (61 shared papers)Matthias Grell (23 shared papers)Ulrich S Zimmermann (11 shared papers)Ugur Üçer (11 shared papers)Bettina Thoma (7 shared papers)Martin Krönke (18 shared papers)Daniela Siegmund (7 shared papers)
- Journals
- Journal of Biological Chemistry (16 papers)The Journal of Immunology (10 papers)European Journal of Immunology (7 papers)PLoS ONE (7 papers)The Journal of Experimental Medicine (6 papers)
- Partner nations
- GermanyUnited KingdomIreland
In The Last Decade
Peter Scheurich
156 papers receiving 13.4k citations
Peter Scheurich's Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 2.2k
- Immunology 2.8k
- Molecular Biology 5.3k
- Oncology 1.8k
- Neurology 416
Countries citing papers authored by Peter Scheurich
This map shows the geographic impact of Peter Scheurich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Scheurich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Scheurich more than expected).
Fields of papers citing papers by Peter Scheurich
This network shows the impact of papers produced by Peter Scheurich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Scheurich. The network helps show where Peter Scheurich may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Scheurich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor necrosis factor signaling Hit paper breakdown → | 2003 | 1974 |
| 2 | The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor Hit paper breakdown → | 1995 | 1169 |
| 3 | 2001 | 519 | |
| 4 | 1987 | 448 | |
| 5 | 1998 | 387 | |
| 6 | 2001 | 313 | |
| 7 | 1999 | 250 | |
| 8 | 2011 | 245 | |
| 9 | 2004 | 244 | |
| 10 | 1981 | 241 | |
| 11 | 2004 | 240 | |
| 12 | 2002 | 237 | |
| 13 | 1987 | 224 | |
| 14 | 2004 | 216 | |
| 15 | 1990 | 188 | |
| 16 | 2001 | 187 | |
| 17 | 2002 | 176 | |
| 18 | 1981 | 173 | |
| 19 | 2000 | 166 | |
| 20 | 1997 | 165 |
About Peter Scheurich
Peter Scheurich is a scholar working on Cancer Research, Immunology, Oncology, Molecular Biology and Biotechnology, having authored 159 papers that have together received 14k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (48 papers), NF-κB Signaling Pathways (45 papers), Cytokine Signaling Pathways and Interactions (36 papers), Gene Regulatory Network Analysis (13 papers), T-cell and B-cell Immunology (12 papers), Immune Response and Inflammation (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Microbial Inactivation Methods (8 papers). The work is most often cited by research in Cancer Research (2.2k citations), Immunology (2.8k citations), Molecular Biology (5.3k citations), Oncology (1.8k citations) and Neurology (416 citations). Peter Scheurich has collaborated with scholars based in Germany, United Kingdom and Ireland. Frequent co-authors include Harald Wajant, Klaus Pfizenmaier, Matthias Grell, Ulrich S Zimmermann, Ugur Üçer, Bettina Thoma, Martin Krönke, Daniela Siegmund, Frank Henkler and Sebastian Kreuz. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology, European Journal of Immunology, PLoS ONE and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.